Knee OA drug safety check: 16 volunteers tracked for years
NCT ID NCT05752032
First seen Mar 29, 2026 · Last updated Apr 30, 2026 · Updated 1 time
Summary
This study follows 16 people who previously received the experimental drug ICM-203 or a placebo for knee osteoarthritis. Researchers will monitor for any delayed side effects and measure changes in knee pain and function over time. The goal is to understand the long-term safety and effectiveness of the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barwon Health
Geelong, Victoria, 3220, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.